Q4 Clinical trials round-up: October to December 2025
We round up the key data and innovations in Q4 2025 - and what these likely presage for 2026’s R&D focus.
Newsletters and Deep Dive digital magazine
We round up the key data and innovations in Q4 2025 - and what these likely presage for 2026’s R&D focus.
Eloise McLennan looks at a set of signals areas where pressure is building and 2026 looks set to demand more clarity, discipline, and follow-through.
An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.
Dermot Kenny, who leads STEM and Research Partnership at Inizio Advisory, shares his journey from bench scientist to CEO in a new 12 Questions With.
Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.
Editor's Picks
Newsletters and Deep Dive
digital magazine